tiprankstipranks
Trending News
More News >
Angelalign Technology Inc. (HK:6699)
:6699
Hong Kong Market

Angelalign Technology Inc. (6699) AI Stock Analysis

Compare
5 Followers

Top Page

HK

Angelalign Technology Inc.

(6699)

Rating:65Neutral
Price Target:
HK$60.00
▲(4.08%Upside)
The overall stock score of 65 reflects a combination of strong financial performance and stable technical indicators, offset by significant overvaluation concerns. The company's financial growth potential is notable, but high P/E ratio and lack of dividends suggest caution.

Angelalign Technology Inc. (6699) vs. iShares MSCI Hong Kong ETF (EWH)

Angelalign Technology Inc. Business Overview & Revenue Model

Company DescriptionAngelalign Technology Inc. (6699) is a leading company in the orthodontic industry, specializing in the design, manufacturing, and marketing of invisible orthodontic products. The company operates primarily in the healthcare sector, offering innovative solutions for dental alignment through their flagship product line, Angelalign clear aligners. These products are primarily used by orthodontic professionals to treat patients seeking aesthetic and effective alternatives to traditional metal braces.
How the Company Makes MoneyAngelalign Technology Inc. generates revenue primarily through the sale of its Angelalign clear aligners. The company's revenue model is based on manufacturing these orthodontic devices and selling them directly to orthodontists and dental professionals who then provide the aligners to patients as part of orthodontic treatments. Key revenue streams include direct product sales and distribution partnerships with dental clinics and healthcare providers. The company's earnings are significantly influenced by its ability to innovate and maintain competitive pricing, as well as its strategic partnerships with orthodontic practices that drive product adoption and market penetration.

Angelalign Technology Inc. Financial Statement Overview

Summary
Angelalign Technology Inc. shows strong revenue growth with a solid balance sheet, but challenges in profitability and cash flow management pose risks. The recent recovery in margins indicates a positive outlook.
Income Statement
75
Positive
Angelalign Technology Inc. displayed strong revenue growth from 2019 to 2024, with a noticeable increase in gross profit margin. However, volatile EBIT and net profit margins, especially the negative EBIT in 2023, indicate instability in profitability management. The recent improvement in 2024 suggests recovery and better cost control.
Balance Sheet
85
Very Positive
The company maintains a solid balance sheet with a low debt-to-equity ratio, signifying financial stability. The equity ratio is robust, indicating a strong equity base relative to its assets. Return on equity showed fluctuations but remains positive, highlighting effective use of equity capital.
Cash Flow
65
Positive
Operating cash flow has been positive but varied significantly over the years. Free cash flow turned negative in 2024, primarily due to increased capital expenditures, raising concerns about cash management. The operating cash flow to net income ratio is consistent, reflecting dependable cash earnings.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.96B1.48B1.27B1.27B816.53M
Gross Profit1.23B920.71M785.69M826.65M575.05M
EBITDA77.34M154.39M318.65M372.47M224.51M
Net Income88.42M53.48M213.78M285.85M150.69M
Balance Sheet
Total Assets4.95B4.76B4.49B4.14B1.21B
Cash, Cash Equivalents and Short-Term Investments3.19B3.44B3.65B3.63B877.58M
Total Debt14.48M65.28M28.20M30.29M14.17M
Total Liabilities1.44B1.35B884.01M826.11M712.47M
Stockholders Equity3.46B3.34B3.61B3.32B501.70M
Cash Flow
Free Cash Flow-76.78M51.28M51.48M241.95M366.61M
Operating Cash Flow123.48M165.87M146.87M441.71M408.28M
Investing Cash Flow-1.01B-981.71M-159.77M-182.05M-7.28M
Financing Cash Flow-207.73M-187.06M-193.61M2.52B-23.33M

Angelalign Technology Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price57.65
Price Trends
50DMA
54.61
Positive
100DMA
56.51
Positive
200DMA
58.05
Negative
Market Momentum
MACD
0.60
Positive
RSI
52.98
Neutral
STOCH
71.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6699, the sentiment is Positive. The current price of 57.65 is above the 20-day moving average (MA) of 57.08, above the 50-day MA of 54.61, and below the 200-day MA of 58.05, indicating a neutral trend. The MACD of 0.60 indicates Positive momentum. The RSI at 52.98 is Neutral, neither overbought nor oversold. The STOCH value of 71.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:6699.

Angelalign Technology Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
€10.23B16.1518.36%21.75%7.13%13.39%
77
Outperform
$27.63B12.388.95%4.42%-3.09%0.67%
74
Outperform
€4.04B9.9815.04%4.26%6.05%1.32%
68
Neutral
HK$17.66B33.0328.81%0.94%14.99%31.70%
67
Neutral
HK$4.40B19.7611.24%1.20%11.23%20.39%
65
Neutral
HK$9.84B203.751.33%0.66%
60
Neutral
HK$15.58B5.65-7.43%4.32%11.60%-21.06%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:6699
Angelalign Technology Inc.
57.05
-1.25
-2.14%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
37.15
25.50
218.88%
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
24.20
-1.90
-7.28%
HK:1066
Shandong Weigao Group Medical Polymer Co
6.11
2.47
67.81%
HK:3600
Modern Dental Group Limited
4.32
0.42
10.77%
HK:9997
Kangji Medical Holdings Limited
8.66
3.27
60.61%

Angelalign Technology Inc. Corporate Events

Angelalign Technology Inc. Announces Board and Committee Appointments
Jun 24, 2025

Angelalign Technology Inc. has announced the composition of its board of directors and the establishment of key committees, including the Audit, Remuneration, and Nomination Committees. This strategic move is aimed at strengthening the company’s governance structure and enhancing its operational efficiency, potentially impacting its market positioning and stakeholder relations positively.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Secures Raw Material Supply for Clear Aligners
Jun 24, 2025

Angelalign Technology Inc. has announced that its subsidiary, Wuxi EA, has entered into a Product Purchase Cooperation Framework Agreement with Shanghai Kaihao, a company associated with a substantial shareholder of Angelalign. This agreement involves the purchase of raw materials for the production of clear aligners over an 18-month period, with set annual caps for purchases. The transactions are classified as continuing connected transactions under Hong Kong’s Listing Rules, requiring reporting and annual review but exempt from independent shareholder approval. This strategic move is expected to secure essential materials for Angelalign’s production, potentially enhancing its market position in the orthodontic industry.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Grants RSUs to Boost Employee Motivation
Jun 24, 2025

Angelalign Technology Inc. has announced the grant of 736,920 restricted share units (RSUs) to 231 employees under its post-IPO RSU scheme, aimed at providing long-term motivation. The RSUs will vest in four tranches over four years, with performance targets and a clawback mechanism in place. This initiative is part of the company’s strategy to offer competitive remuneration and align employee incentives with company performance, potentially strengthening its market position and stakeholder confidence.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Updates Nomination Committee Terms
Jun 24, 2025

Angelalign Technology Inc. has announced the amendment and restatement of the terms of reference for its Nomination Committee, effective from June 24, 2025. This move is part of the company’s ongoing efforts to enhance corporate governance and ensure a diverse and independent board structure, potentially impacting its operational efficiency and stakeholder confidence.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$84.95 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Successfully Concludes Annual General Meeting with Key Resolutions Passed
May 23, 2025

Angelalign Technology Inc. announced the results of its Annual General Meeting held on May 23, 2025, where all proposed resolutions were passed with significant shareholder support. Key resolutions included the approval of financial statements, granting of mandates for share issuance and buybacks, re-election of directors, re-appointment of auditors, and the declaration of a special final dividend. The successful passing of these resolutions indicates strong shareholder confidence and positions the company for continued strategic growth and operational stability.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$84.95 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Announces Key Leadership Changes
May 15, 2025

Angelalign Technology Inc. announced the resignation of Mr. Zhu Lingbo from his roles as senior vice president, board secretary, company secretary, and authorized representative, effective May 15, 2025. Mr. Zhu’s resignation is amicable, with no disagreements reported. In his place, Mr. Lee Leong Yin has been appointed as the new company secretary and authorized representative. Mr. Lee, nominated by Tricor Services Limited, brings over 14 years of experience in corporate secretarial services and holds relevant professional qualifications. This change in leadership is expected to maintain the company’s compliance with listing rules and support its corporate governance framework.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$86.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Issues Supplemental Announcement on Connected Transactions
Apr 29, 2025

Angelalign Technology Inc. has issued a supplemental announcement regarding its continuing connected transactions under Rule 14A.60 of the Listing Rules. The announcement clarifies that the processing service fee for raw materials is fixed and was determined when the Processing Undertaking Agreement was established. This additional information does not alter the previous announcement’s content and maintains the validity of the original details.

Angelalign Technology Announces 2025 AGM Details
Apr 22, 2025

Angelalign Technology Inc. has announced the details of its upcoming Annual General Meeting (AGM), scheduled for May 23, 2025, in Shanghai, China. During the AGM, shareholders will consider resolutions including the approval of audited financial statements for 2024 and granting the directors authority to issue additional shares. This meeting is significant for stakeholders as it involves decisions on financial performance and potential share issuance, impacting the company’s strategic direction and shareholder value.

Angelalign Technology Inc. Strengthens Supply Chain with Shanghai Kaihao Partnership
Apr 21, 2025

Angelalign Technology Inc. has announced that Shanghai Kaihao has become a connected person of the company following a significant equity acquisition by a substantial shareholder. This development has led to the classification of existing transactions under a Processing Undertaking Agreement as continuing connected transactions, necessitating compliance with specific disclosure and review requirements. The agreement, which involves Shanghai Kaihao providing processing services for raw materials used in clear aligner production, is seen as a strategic move to secure reliable suppliers and support the company’s growth in the clear aligner market. The terms of the agreement are deemed fair and beneficial for the company’s operations and stakeholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 24, 2025